[1]
Oscanoa, T. et al. 2020. Clinical characteristics of pyrazinamide-associated hepatotoxicity in patients at a hospital in Lima, Peru. Revista Peruana de Medicina Experimental y Salud Pública. 37, 3 (Sep. 2020), 516–20. DOI:https://doi.org/10.17843/rpmesp.2020.373.4684.